Creatine Mental Fatigue Meta-analysis: What the Evidence Says

Quick Answer

Creatine Mental Fatigue Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• This "lactate-pyruvate shuttle" improves energy efficiency and limits the accumulation of metabolites associated with muscle fatigue. [Larrea Ane (2026); evidence level 3]
• Improvements are also observed in respiratory chain efficiency, with increased activity of complexes I-IV and ATP synthase, reducing uncoupling and oxidative stress. [Larrea Ane (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For creatine mental fatigue meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Larrea Ane (2026). Revision of Energy Metabolism Adaptations in High-Level Athletes: From Physical Performance Enhancement to Potential Therapeutic Targets in Mental Disorders. DOI: 10.3390/cimb48050498. PMCID: PMC13204626. PMID: 42193103. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13204626/
• Kerksick Chad (2026). The emerging and evolving evidence supporting creatine as an ergogenic aid: history and applications. DOI: 10.1080/15502783.2026.2646627. PMCID: PMC13011109. PMID: 41870601. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13011109/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.